Advanced search
Publication Cover
All Life Volume 14, 2021 - Issue 1
Submit an article Journal homepage
1,009
Views
2
CrossRef citations to date
0
Altmetric
Cancer Biology

Circ_0000518 contributes to breast cancer development depending on the regulation of miR-1258/ZEB1 axis

Guojun LiuDepartment of Surgical Oncology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, People’s Republic of China
&
Xuqun HuangDepartment of Surgical Oncology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, People’s Republic of ChinaCorrespondence[email protected]
Pages 195-208 | Received 09 Dec 2020, Accepted 10 Feb 2021, Published online: 18 Mar 2021

References

  • Azim HA Jr, Partridge AH. 2014. Biology of breast cancer in young women. Breast Cancer Res. 16:427.
  • Caramel J, Ligier M, Puisieux A. 2018. Pleiotropic roles for ZEB1 in cancer. Cancer Res. 78:30–35.
  • Cui Y, Qin L, Tian D, Wang T, Fan L, Zhang P, Wang Z. 2019. ZEB1 promotes chemoresistance to cisplatin in ovarian cancer cells by suppressing SLC3A2. Chemotherapy. 63:262–271.
  • Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 79:351–379.
  • Fang J, Huang C, Ke J, et al. 2020. lncRNA TTN-AS1 facilitates proliferation, invasion, and epithelial-mesenchymal transition of breast cancer cells by regulating miR-139-5p/ZEB1 axis. J Cell Biochem.
  • Froes Brandao D, Strasser-Weippl K, Goss PE. 2016. Prolactin and breast cancer: the need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: a review. Cancer. 122:184–188.
  • Goldvaser H, Amir E. 2019. Role of bisphosphonates in breast cancer therapy. Curr Treat Options Oncol. 20:26.
  • Harbeck N, Gnant M. 2017. Breast cancer. The Lancet. 389:1134–1150.
  • Hata A, Lieberman J. 2015. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal. 8:re3.
  • Hu M, Wang M, Lu H, Wang X, Fang X, Wang J, Ma C, Chen X, Xia H. 2016. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B. Oncotarget. 7:43419–43431.
  • Jiang Y, Jin S, Tan S, Shen Q, Xue Y. 2019. MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1. Onco Targets Ther. 12:6093–6104.
  • Jiang J, Lin H, Shi S, Hong Y. 2020. Bai X and Cao X: Hsa_circRNA0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis. Thorac Cancer. 11:3181–3192.
  • Jiang W, Wei K, Pan C, Li H, Cao J, Han X, Tang Y, Zhu S, Yuan W, He Y, et al. 2018. MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif. 51:e12502.
  • Jiang X, Zhou Y, Sun AJ, Xue JL. 2018. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. J Cell Physiol. 233:8558–8566.
  • Kulcheski FR, Christoff AP, Margis R. 2016. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 238:42–51.
  • Liang TC, Fu WG, Zhong YS. 2019. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1. Eur Rev Med Pharmacol Sci. 23:9988–9995.
  • MacNeill F, Karakatsanis A. 2017. Over surgery in breast cancer. The Breast. 31:284–289.
  • Panda AC. 2018. Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 1087:67–79.
  • Peng X, Zhang Y, Gao J, Cai C. 2020. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway. Exp Mol Pathol. 114:104368.
  • Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R, Li H. 2018. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 414:301–309.
  • Sun M, Zhao W, Chen Z, Li M, Li S, Wu B, Bu R. 2019. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p. J Cell Physiol. 234:4812–4824.
  • Yong W, Zhuoqi X, Baocheng W, Dongsheng Z, Chuan Z, Yueming S. 2018. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer. Biomed Pharmacother. 102:1188–1194.
  • Zhang L, Sullivan PS, Goodman JC, Gunaratne PH, Marchetti D. 2011. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res. 71:645–654.
  • Zhang P, Sun Y, Ma L. 2015. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle. 14:481–487.
  • Zhao X. 2020. miR-1258 regulates cell proliferation and cell cycle to inhibit the progression of breast cancer by targeting E2F1. BioMed Res Int. 2020:1480819.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.